Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.51 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.51 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 2/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4597676 | 1.00 | DGKA (0.59) | DGKAALDH1A1PRSS1PRSS2PRSS3 | |
| SCHEMBL20500772 | 1.00 | DGKA (0.59) | DGKAALDH1A1PRSS1PRSS2PRSS3 | |
| SCHEMBL18957507 | 1.00 | DGKA (0.59) | DGKAALDH1A1PRSS1PRSS2PRSS3 | |
| SCHEMBL18957516 | 0.95 | DGKA (0.61) | DGKAALDH1A1PRSS1PRSS2PRSS3 | |
| SCHEMBL18957526 | 0.94 | DGKA (0.59) | DGKAALDH1A1PRSS1PRSS2PRSS3 | |
| SCHEMBL18957525 | 0.94 | DGKA (0.54) | DGKAALDH1A1PRSS1PRSS2PRSS3 | |
| SCHEMBL10309225 | 0.94 | DGKA (0.53) | DGKAALDH1A1PRSS1PRSS2PRSS3 | |
| SCHEMBL11909958 | 0.93 | DGKA (0.51) | DGKAALDH1A1PRSS1PRSS2PRSS3 | |
| SCHEMBL11909330 | 0.93 | DGKA (0.51) | DGKAALDH1A1PRSS1PRSS2PRSS3 | |
| SCHEMBL11779501 | 0.92 | DGKA (0.44) | DGKAALDH1A1PRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114716763-B | Aging-resistant conductive polypropylene functional material and preparation method thereof | 华润化学材料科技股份有限公司 | 2023-07-25 | — | — | CN | claimed |
| US-20260049203-A1 | CURABLE COMPOSITION | KANEKA NORTH AMERICA LLC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4692247-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260022211-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| CN-119894958-A | Photocurable resin sheet | 日东电工株式会社 | 2025-04-25 | — | — | CN | disclosed |
| WO-2025063290-A1 | METHOD FOR PRODUCING POLYOXYALKYLENE-BASED POLYMER, POLYOXYALKYLENE-BASED POLYMER, AND CURABLE COMPOSITION | 株式会社カネカ | 2025-03-27 | — | — | WO | disclosed |
| WO-2025063292-A1 | CURABLE COMPOSITION | 株式会社カネカ | 2025-03-27 | — | — | WO | disclosed |
| WO-2025063291-A1 | POLYOXYALKYLENE POLYMER, METHOD FOR PRODUCING POLYOXYALKYLENE POLYMER, AND CURABLE COMPOSITION | 株式会社カネカ | 2025-03-27 | — | — | WO | disclosed |
| CN-119585651-A | Composition for forming wavelength conversion film | 日产化学株式会社 | 2025-03-07 | — | — | CN | disclosed |
| CN-119065201-A | Radiation-sensitive composition, cured film, method for producing same, semiconductor element, and display element | JSR株式会社 | 2024-12-03 | — | — | CN | disclosed |
| US-5703150-A | STABILIZERS; HEAT, OXIDATION RESISTANCE | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1997-12-30 | — | — | US | disclosed |
| CN-1133318-A | Thermo-insulating resin foam rising body and making method thereof | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 1996-10-16 | — | — | CN | disclosed |
| EP-0719781-A1 | Phosphonous, phosphinous or phosphonic acid derivatives as stabilizers for organic materials | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1996-07-03 | — | — | EP | disclosed |
| EP-0473793-B1 | CURABLE COMPOSITION | KANEGAFUCHI CHEMICAL IND (JP) | 1996-06-12 | — | — | EP | disclosed |
| EP-0700953-A2 | Thermal insulating foamed material and method for manufacturing the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1996-03-13 | — | — | EP | disclosed |
| EP-0473793-A1 | CURABLE COMPOSITION | Kanegafuchi Chemical Industry Co., Ltd. (JP) | 1992-03-11 | — | — | EP | disclosed |
| EP-0398561-A2 | Method for stabilizing organic phosphoric ester and soil pest controlling agent containing, as active ingredient, compound stabilized by the method | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-11-22 | — | — | EP | disclosed |
| EP-0029316-B2 | VINYLIDENE CHLORIDE COPOLYMER RESIN COMPOSITION, PACKAGING FILM PREPARED THEREFROM AND FOOD PACKAGES USING THE FILM | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-06-24 | — | — | EP | disclosed |
| EP-0029316-B1 | VINYLIDENE CHLORIDE COPOLYMER RESIN COMPOSITION, PACKAGING FILM PREPARED THEREFROM AND FOOD PACKAGES USING THE FILM | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1983-02-16 | — | — | EP | disclosed |
| EP-0029316-A1 | Vinylidene chloride copolymer resin composition, packaging film prepared therefrom and food packages using the film | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1981-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049203-A1 | CURABLE COMPOSITION | FLNA, FLNB, FSCN1 | DGKA 3826/4885ALDH1A1 3439/4885PRSS1 2904/4885 |
| US-20260022211-A1 | CURABLE COMPOSITION | H1-4, H1-0, H1-2 | DGKA 3976/4885ALDH1A1 2939/4885PRSS1 4262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.